Ninlaro is a prescription medication used in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This drug belongs to a class of medications known as proteasome inhibitors, which work by blocking the action of proteasomes, enzymes that break down proteins in cells.

Ninlaro is typically prescribed in combination with other medications, such as dexamethasone and lenalidomide, for patients who have already received at least one prior treatment for their multiple myeloma. It is taken orally in capsule form once a week for three weeks followed by a one-week break.

As with any medication, Ninlaro may cause side effects. Common side effects include nausea, diarrhea, fatigue, and low blood cell counts. It is important to discuss any side effects with your healthcare provider, as they may be able to provide recommendations for managing them.

It is also important to follow your healthcare provider’s instructions carefully when taking Ninlaro. This includes taking the medication at the same time each week, not missing any doses, and not taking any other medications or supplements without first consulting your healthcare provider.

If you have been prescribed Ninlaro for the treatment of multiple myeloma, it is important to stay in close communication with your healthcare provider throughout your treatment. They will monitor your progress and make any necessary adjustments to your treatment plan to ensure the best possible outcome.

Overall, Ninlaro is an important medication in the treatment of multiple myeloma and can help improve outcomes for patients with this condition. If you have any questions or concerns about Ninlaro, be sure to discuss them with your healthcare provider.